Anthrax bacterium's deadly secrets probedAugust 07, 2007New insights into why the bug that causes anthrax behaves in the unusual way that it does have come to light thanks to a development under the UK e-Science Programme. Researchers at the North East Regional e-Science Centre have found that the proteins the anthrax bacterium secretes equip it to grow only in an animal host and not in the soil. This finding sheds light on why Bacillus anthracis does not grow in soil, even though in many ways it resembles a soil-growing bacterium. It has the ability to lie dormant in soil for, in some cases, hundreds of years and then to cause a rapid, often fatal, illness when ingested by a suitable animal host. Bioterrorists have exploited this ability to deadly effect. Dr. Anil Wipat, Professor Colin Harwood, Tracy Craddock and colleagues at the North East Regional e-Science Centre in Newcastle revealed the new insights after developing a method for deducing and characterising the proteins a bacterium secretes simply from a knowledge of its genome sequence.
Secreted proteins equip a bacterium to survive in its environment and so reveal much about its lifestyle. A soil-living bacterium, for example, secretes proteins that enable it to take up nutrients from the soil. A disease-causing bacterium may secrete proteins that subvert the host's immune system, enabling the bacterium to infect cells or survive in the bloodstream. Knowledge of a pathogenic bacterium's secreted proteins and how they function can therefore help with the search for treatments. As genes carry the code for proteins, researchers are able to use knowledge of a bacterium's genes to deduce all the proteins it produces. Difficulty arises when trying to pick out only the proteins that are secreted. Methods exist to do this, but are very time-consuming, given that many bacteria secrete 4000 or more proteins. Now, however, the Newcastle researchers have developed an automatic method which makes the identification, analysis and comparison of bacterial secreted proteins from many organisms a realistic proposition. Based on Taverna workflow technology, which was developed under myGrid, an e-Science project funded by the Engineering and Physical Sciences Research Council (EPSRC), it performs a series of analyses on all the proteins produced by a bacterium to create, by a process of selection and elimination, a list of secreted proteins and their properties. The results are stored in a database. Before this new method, researchers would have had to perform these operations manually, often retrieving algorithms for performing the analyses from separate, distributed computers. The team decided to test their method on 12 members of the Bacillus family. Family members exhibit a variety of behaviours ranging from the friendly Bacillus subtilis, which lives in the soil, promotes plant growth and is used to produce industrial enzymes and vitamins, to the deadly Bacillus anthracis, which causes anthrax. The full complement of proteins produced by the Bacillus family was fed into the workflow. The number of secreted proteins predicted for each member ranged between 350 and 500. The secreted proteins were then put through a second workflow which placed them into groups of proteins with similar functions. Of particular interest were groups containing proteins secreted only by pathogenic members and only by non-pathogenic members. Secreted proteins unique to the non-pathogenic bacteria have functions that enable them to live in their habitats, whereas almost all of those unique to the pathogenic family members were of unknown function. The predicted secreted proteins from Bacillus anthracis help to explain its inability to grow in soil. "When we looked at the secreted proteins, we found that they're not adapted to utilise molecules in the soil," says Professor Harwood. However, they do enable Bacillus anthracis to grow in an animal host. Some breakdown animal protein such as muscle fibres, others are the toxins which eventually kill the host, but others belong to the group of proteins of unknown function unique to pathogenic bacteria. "We don't know what these latter proteins do but we think they help the organism to evade the immune response," says Professor Harwood. "We're beginning to understand why Bacillus anthracis behaves in the way that it does -and how it has adapted only to grow in the host and not in the soil," he adds. The team is setting up a website to guide users through the process for any bacterium whose genome is known. By identifying the secreted proteins it will be possible to determine some of the previously unsuspected properties of a bacterium, including whether it is likely to be pathogenic or not. The method is also showing promise of commercial application as many enzymes sold commercially, such as plant-derived enzymes used for biofuel production, are proteins harvested from bacteria which secrete them naturally. Research Councils UK | |||||||||||||||||||||
|
Related Anthrax Current Events and Anthrax News Articles Nature study demonstrates that bacterial clotting depends on clustering Bacteria can directly cause human blood and plasma to clot-a process that was previously thought to have been lost during the course of vertebrate evolution, according to new research at the University of Chicago, National Institute of Allergy and Infectious Diseases, and Institut Pasteur in Paris. Their findings will be published online Nov. 2 in Nature Chemical Biology. UCLA develops safer, more effective TB vaccine for HIV-positive people UCLA scientists engineered a new tuberculosis (TB) vaccine specifically designed for HIV-positive people that was shown to be safer and more potent than the current TB vaccine in preclinical trials. Green catalysts provide promise for cleaning toxins and pollutants Tetra-Amido Macrocyclic Ligands (TAMLs) are environmentally friendly catalysts with a host of applications for reducing and cleaning up pollutants, and a prime example of "green chemistry." Carnegie Mellon University's Terry Collins, the catalyst's inventor, believes that the small-molecule catalysts have the potential to be even more effective than previously proven. Nano vaccine for hepatitis B shows promise for third world Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. Francisella tularensis: Stopping a biological weapon Scientists hope a vaccine is on the horizon for tularemia, a fatal disease caused by the pathogen Francisella tularensis, an organism of concern as a potential biological warfare agent. Until recently we knew very little about this bacterium. Effective health messages may yield vaccine compliance among ER workers Emergency room workers will be the first line of defense in the event of a disease pandemic and will be forced to deal with the chaos that inevitably comes with treating thousands of sick and dying. In order to protect themselves and allow them to care for the public, these first responders need to be fully prepared by getting available vaccines now. Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances Security and law enforcement officials may some day have a new ally - a universal detection system that can monitor the air for virtually all of the major threat agents that could be used by terrorists. New strategies against bird flu The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). NIST, Army researchers pave the way for anthrax spore standards Researchers from the National Institute of Standards and Technology (NIST) and the U.S. Army Dugway (Utah) Proving Ground have developed reliable methods based on DNA analysis to assess the concentration and viability of anthrax spores after prolonged storage. Protein data bank archives 50,000th molecule structure The Protein Data Bank (PDB) based at Rutgers, The State University of New Jersey, and the University of California-San Diego (UCSD) this month reached a significant milestone in its 37-year history. The 50,000th molecule structure was released into its archive, joining other structures vital to pharmacology, bioinformatics and education. More Anthrax Current Events and Anthrax News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||